Rekombinanter ERCC1 Antikörper

Produktnummer ABIN7828192

Dieser Kaninchen Monoklonal Antikörper detektiert spezifisch ERCC1 in IHC. Es zeigt Reaktivität gegenüber Proben von Human, Maus und Ratte.

Kurzübersicht für Rekombinanter ERCC1 Antikörper (ABIN7828192)

Target: ERCC1 (Excision Repair Cross Complementing Polypeptide-1 (ERCC1))

Antikörpertyp: Recombinant Antibody

Reaktivität: Human, Maus, Ratte

Wirt: Kaninchen

Klonalität: Monoklonal

Konjugat: Dieser ERCC1 Antikörper ist unkonjugiert

Applikation: Immunohistochemistry (IHC)

Klon: A216

Produktdetails anti-ERCC1 Antikörper

Verwendungszweck: Recombinant ERCC1 Monoclonal Antibody

Aufreinigung: Protein A purified

Immunogen: Recombinant human ERCC1 fragment

Isotyp: IgG, kappa

Anwendungsinformationen

Applikationshinweise: IHC 1:200-1:1000

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Konzentration: 1 mg/mL

Buffer: PBS, 50 % glycerol, 0.05 % Proclin 300, 0.05 % protein protectant.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20°C Valid for 12 months. Avoid freeze / thaw cycles.

Haltbarkeit: 12 months

Details zu ERCC1

Target: ERCC1 (Excision Repair Cross Complementing Polypeptide-1 (ERCC1))

Andere Bezeichnung: ERCC1

Hintergrund: Ercc,ERCC1,COFS 4,COFS4,DNA excision repair protein ERCC 1,DNA excision repair protein ERCC1,DNA excision repair protein ERCC-1,endonuclease non-catalytic subunit,ERCC 1,ERCC excision repair 1,Excision repair cross complementation group 1,Excision repair cross complementing 1,Excision Repair Cross Complementing Rodent Repair Deficiency Complementation Group 1,excision repair cross-complementation group 1,Excision repair protein,RAD 10,RAD10,UV 20,UV20,Non-catalytic component of a structure-specific DNA repair endonuclease responsible for the 5'-incision during DNA repair. Participates in the processing of anaphase bridge-generating DNA structures, which consist in incompletely processed DNA lesions arising during S or G2 phase, and can result in cytokinesis failure. Cat.No. Product Name Clone No. IF:{{item.impact}} Journal:{{item.journal}} ({{item.year}}) DOI:{{item.doi}} Reactivity:{{item.species}} Sample Type:{{item.sample_type}} Previous {{ page }} Next Q{{(FAQpage.currentPage - 1)*pageSize+index+1}}:{{item.name}} Previous {{ page }} Next [

UniProt: P07992

Pathways: DNA Reparatur, Production of Molecular Mediator of Immune Response